Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Public-Private Investments to Fund Product Development
4.2.2 Increasing Research to Establish the Clinical Efficacy of Cell Encapsulation
4.2.3 Rising Public Awareness for Role of Encapsulated Cells in Disease Management
4.3 Market Restraints
4.3.1 Limited Availability of Good Quality Raw Material
4.3.2 Adoption of Alternative Therapies
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Manufacturing Technique
5.1.1 Simple Dripping
5.1.2 Electrostatic Dripping
5.1.3 Coaxial Airflow
5.1.4 Rotating Disk Atomization
5.1.5 Others
5.2 By Polymer Type
5.2.1 Alginate
5.2.2 Chitosan
5.2.3 Silica
5.2.4 Cellulose Sulfate
5.2.5 Others
5.3 By Application
5.3.1 Drug Delivery
5.3.2 Regenerative Medicine
5.3.3 Cell Transplantation
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Viacyte, Inc.
6.1.2 Living Cell Technologies Limited.
6.1.3 Diatranz Otsuka Ltd
6.1.4 PharmaCyte Biotech Inc
6.1.5 Sernova Corp
6.1.6 Sigilon Therapeutics, Inc.
6.1.7 Buchi Labortechnik AG
6.1.8 Blacktrace Holdings Ltd.
6.1.9 Atelerix Ltd.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS